Press Releases

 Filter by Provider

AcuityMD, the MedTech Intelligence Platform, today announced a new solution that will help MedTech companies and healthcare providers (HCPs) deliver new treatment options to more patients. Referral Pathways in AcuityMD Care Journeys provides comprehensive patient referral data so MedTech commercial teams can easily identify the physicians who can most benefit from their products and bring innovations to more patients.

India based Hindustan Zinc Limited, a Vedanta Group company and the world’s largest integrated zinc producer, announced its financial results for the year ended 31st March 2025 on 25th April 2025. The company recorded its ever-highest annual production of mined and refined metal of 1,095 KT and 1,052 KT respectively. The company delivered robust financials with FY25 revenue soaring 18% YoY to US$ 4,031 million. Hindustan Zinc also registered a robust FY25 EBITDA of US$ 2,066 million, up 28% YoY with an industry leading margin of c.51%, up 400 bps YoY. The company delivered robust full year profit after tax of US$ 1,224 million, up 33% YoY driven by 4-year lowest zinc cost of production at US$ 1,052/Mt. Hindustan Zinc recorded the highest-ever Return on Capital Employed^ of 58%, best in the industry. In FY25, Hindustan Zinc generated strong Free Cash Flow from operations (pre-capex) of US$ 1,630 million. In FY25, Hindustan Zinc delivered total shareholder returns of c.68% and ranks among the Top 3 companies in India’s Nifty Metal Index with a market capitalization of US$ 23 billion. The company has recently been included in the Futures & Options (F&O) segment on the National Stock Exchange (NSE). The company has consistently maintained an investment grade rating of AAA from CRISIL. Hindustan Zinc holds the second highest zinc reserves & resources globally with 25+ years of mine life and also surpassed 13.1 Mt of metal reserves (net of 1.2 Mt production) for the first time^.

Eldridge Real Estate Credit and Hillwood today announced the provision of two debt facilities for the development and construction of industrial units in Swanley and Park Royal, UK. These transactions total over £57.6 million, and they mark the second and third financings between Hillwood and Eldridge Real Estate Credit.

Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity

Recognition highlights Narain’s impact in AI-driven drug discovery and biology-first innovation to the biopharma industry

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that Eugene Lei, Chief Financial Officer at Hudbay, has been recognized as a winner of the Globe and Mail’s Report on Business 2025 Best Executives Award. This award recognizes non-CEO leaders who demonstrate exceptional leadership and continue to drive impact for their organizations.

Initial real-world data from nearly 40,000 EYLEA HD patients will provide early insights on effectiveness of EYLEA HD in everyday clinical practice

TORONTO, ON / ACCESS Newswire / April 28, 2025 / Aclara Resources Inc. ("Aclara" or the "Company") (TSX:ARA) is pleased to announce the official inauguration of its semi-industrial heavy rare earths pilot plant facility in Aparecida de Goiania, Goias, Brazil. The ceremony was attended by key government authorities from the State of Goias, the Municipality of Nova Roma, and representatives from federal agencies and international embassies.

International Star Inc. Re-Engages T Bone Capital and Todd Masse to Drive Strategic Growth and Deal Flow

GOLETA, CA / ACCESS Newswire / April 28, 2025 / Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, automotive, AI, defense and aerospace, communication, and quantum computing, announced today that it will visit the Nasdaq MarketSite in Times Square and ring the Closing Bell in celebration of the recent listing of its common stock on the Nasdaq Capital Market.

CRANBROOK, BC / ACCESS Newswire / April 28, 2025 / Eagle Plains Resources Ltd. (TSX-V:EPL) ("EPL" or "Eagle Plains") is pleased provide an update on its 25% owned Olson gold property (the "OlsonProject") in partnership with SKRR Exploration Inc. (SKRR)(B04Q) ("SKRR"), which owns 75% of the Olson Project.

Fourth Quarter 2024 Results Demonstrate Building Momentum in Business

CALGARY, ALBERTA / ACCESS Newswire / April 28, 2025 / Consumer Choice Award is proud to recognize Ultra-Lite Doors as the 2025 winner in the Garage Door Dealers category for Southern Alberta. This respected distinction highlights the Canadiancompany's long-standing commitment to exceptional product quality, expert installation, and responsive customer service throughout the region.

Phillips 66 (NYSE:PSX) (the “Company”) today filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its upcoming Annual Meeting of Shareholders on May 21, 2025.

Today, the U.S. Green Building Council (USGBC) launched LEED v5, the latest version of its flagship LEED (Leadership in Energy and Environmental Design) green building program. LEED v5 builds on the 25-year legacy and global impact of LEED, updating and strengthening the most widely recognized, influential sustainability standard for the building industry while providing user-friendly tools for building owners and teams to pursue certification through enhanced technology updates.

Wayne Wilson, CEO & Founder of SynergenX Health, was named the winner of a Silver Stevie® Award in the Best Entrepreneur - Health Products & Services category in The 23rd Annual American Business Awards®.

Simpson Oil Limited (“Simpson Oil”, “we” or “our”), the largest shareholder of Parkland Corporation (“Parkland” or the “Company”), holding 19.8% of the outstanding common shares, today announced that Glass, Lewis & Co. (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that Parkland shareholders support meaningful boardroom change by voting for seven of its nine director nominees at the Company’s Annual General Meeting (the “Meeting” or the “AGM”) to be held on May 6, 2025.

Americas Gold and Silver Corporation (TSX: USA, NYSE American: USAS) (“Americas” or the “Company”) is pleased to announce that the Company has been included in the Solactive Global Silver Miners Index (“Silver Index”) effective May 1, 2025.

RSA, the security-first identity leader, today announced groundbreaking cybersecurity innovations at RSAC Conference 2025 that defend organizations against the next wave of AI powered identity attacks, including IT Help Desk bypasses, malware, social engineering, and other threats. These advancements are especially critical for organizations implementing passwordless strategies and further solidify RSA's position as the only provider of true, enterprise-ready passwordless identity solutions.

Alliance Resource Partners, L.P. (NASDAQ: ARLP) ("ARLP" or the "Partnership") today reported financial and operating results for the quarter ended March 31, 2025 (the "2025 Quarter"). This release includes comparisons of results to the quarter ended March 31, 2024 (the "2024 Quarter"), and to the quarter ended December 31, 2024 (the "Sequential Quarter"). All references in the text of this release to "net income" refer to "net income attributable to ARLP." For a definition of Adjusted EBITDA and related reconciliation to its comparable GAAP financial measure, please see the end of this release.

While 62 percent of technology and cybersecurity professionals are worried that quantum computing will break today’s internet encryption, only 5 percent say it’s a high priority for the near future, and just 5 percent say their organizations have a defined quantum computing strategy, according to new research from ISACA’s global Quantum Computing Pulse Poll.

Attivare Therapeutics, Inc., an innovative oncology company focused on the development of its ATTimmune biomaterial scaffold cancer therapies to treat patients across a range of solid and liquid tumors with significant unmet medical needs, today announced it will present preclinical data for its novel ATT-01 and ATT-02 therapeutics in two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025.

Celsius Holdings, Inc. (Nasdaq: CELH) today announced that its portfolio brand Alani Nu® surpassed $1 billion in retail sales for the trailing 52-week period ended Apr. 13, 2025, as reported by Circana1. Retail sales increased 72.4% year over year for the same period. This significant milestone has been fueled by accelerated brand growth, strong and unique innovation, and a growing female energy drink consumer segment seeking better-for-you, functional beverages that fit their health and wellness lifestyles.

Anetac, a leader in protecting companies from identity-based vulnerabilities in hybrid environments, today announced the global rollout of Human Link Pro. This powerful new capability unifies the management of human and non-human identity vulnerabilities within the Anetac Identity Vulnerability Management Platform. Already in use by organizations in financial services, retail, healthcare and critical infrastructure, this enhancement addresses the critical need for a single, integrated solution to discover, monitor and respond to vulnerabilities across all identity types–whether employee, non-permanent staff (contractor, partner or supplier) or non-human identities like workloads and service accounts.

Winnipeg, Manitoba--(Newsfile Corp. - April 28, 2025) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"),...

Toronto, Ontario--(Newsfile Corp. - April 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a...

Today, Tropical Smoothie Cafe® has announced the 20 inspiring educators who are now finalists vying for the grand prize in the brand’s Sunshine for Teachers contest. Selected from thousands of nominations submitted by consumers nationwide, these finalists are being recognized and rewarded for spreading sunshine in their classroom and community. In May, one grand prize winner will receive a summer getaway worth up to $10,000 and free smoothies for a year.

In a new whitepaper, Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), says that emerging cost-effective precision strike solutions that can be safely recovered and reused offer a strong alternative to more commonly deployed ‘One-Way Attack’ or First Person View (FPV) drones.

First Farmers and Merchants Corporation (OTC Pink: FFMH), the holding company for First Farmers and Merchants Bank, today announced its results for the first quarter of 2025.

Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T-cell engagers (TCEs), today announced dosing of the initial patient in the GUARDIAN-101 phase 1 trial of CLSP-1025, the first tumor-specific TCE to enter clinical development. CLSP-1025 exclusively targets cancer cells expressing the p53R175H mutation, a mutation associated with a wide range of solid tumors, including colorectal, pancreatic, lung, gastric, esophageal, gynecological, and prostate cancers.

Graylog, the no-nonsense platform for Security, API protection, and IT Operations, today launched its Spring 2025 release of Graylog Security—pushing further past the limits of traditional SIEM. Building on the Fall 2024 release (version 6.1), Graylog sharpens analyst workflows, accelerates time-to-value, and sets a new bar for speed and flexibility in threat detection.

Ziff Davis, Inc. (NASDAQ: ZD) today announced its participation in one investor conference in May.

H Partners Management, LLC (“H Partners” or “we”), one of the largest shareholders of Harley-Davidson, Inc. (NYSE: HOG) (“Harley-Davidson” or the “Company”), which beneficially owns approximately 9.1% of the outstanding shares of the Company, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its campaign to urge shareholders to vote “WITHHOLD” on the election of three long-tenured incumbent directors – CEO and Chairman Jochen Zeitz, Presiding Director Thomas Linebarger, and 29-year director Sara Levinson – at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”) scheduled for May 14, 2025.

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announced the appointment of Mr. Rasmus Holm-Jorgesen as their Chief Financial Officer (CFO). Rasmus brings over 25 years of experience in strategy, finance and global operations within the biopharmaceutical industry to AAVantgarde and has joined the Company’s leadership team, reporting to Dr Natalia Misciattelli, Chief Executive Officer.

WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Monday, May 12, 2025 to report its first quarter 2025 financial results and provide a business update.

LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, and EmeritusDX, a rapidly growing cancer diagnostics and information company, are pleased to announce the expansion of their strategic partnership to include the commercialization of the MSC test for lung cancer screening. This collaboration aims to enhance the accuracy of lung nodule stratification identified via low-dose computed tomography (LDCT), thereby improving patient outcomes and reducing healthcare costs.

All financial results are reported in Canadian dollars, unless otherwise stated.

ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that it has presented results from five preclinical studies during poster presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois, USA.

EXTON, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill patients from mechanical ventilation and may help improve lung, heart, and brain health in ventilated patients.

FAP-EXd (AVA6103) demonstrates tumor growth inhibition and durable complete responses in multiple therapy-resistant preclinical models

Lead development candidate, AMP-410, leverages proprietary Ampersand technology to block VEGF and allosterically activate 4-1BB signaling – unlike traditional bispecific molecules – driving both adaptive and innate anti-tumor activity

FRIENDSWOOD, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its achievement of surpassing a significant milestone of 200,000 DecisionDx-Melanoma clinical test orders. DecisionDx-Melanoma is a 31-gene expression profile test that provides comprehensive, personalized results designed to improve risk-aligned management decisions for patients with stage I-III cutaneous melanoma.

Opal Coalbank consists of nine DUC wells on track for production this summer

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial results and provide a business update on Monday, May 5, 2025.

(All dollar amounts are expressed in CAD dollars, unless stated otherwise)

Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity

Portland Brewery Marks Four Decades of Widmer Beer with ‘40 Years of Cheers’ and Re-release of Four Iconic Brews

Beamr will present at the Ladenburg Thalmann Technology Innovation Expo in New York, and participate virtually in the Needham 1x1 Conference Herzliya, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced the Company will participate in the following investor conferences:

NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, IL.